GENTIUM S.P.A. (ADR) Inactive Instrument
Gentium S.p.A. (ADR) Stock
Equities
US37250B1044
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - | - |
|
Gentium Srl is an Italy-based biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company's development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The main shareholder of the Company is Jazz Pharmaceuticals PLC.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- Stock
